McLean Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$476K Buy
3,959
+118
+3% +$13.6K 0.08% 99
2025
Q4
$426K Buy
3,841
+222
+6% +$20.8K 0.08% 100
2025
Q3
$321K Buy
3,619
+76
+2% +$6.26K 0.07% 123
2025
Q2
$292K Buy
3,543
+125
+4% +$9.94K 0.08% 127
2025
Q1
$270K Sell
3,418
-815
-19% -$76.1K 0.09% 122
2024
Q4
$421K Buy
4,233
+555
+15% +$57.2K 0.13% 85
2024
Q3
$404K Sell
3,678
-26
-0.7% -$3.09K 0.12% 86
2024
Q2
$472K Buy
3,704
+120
+3% +$15.5K 0.15% 78
2024
Q1
$454K Sell
3,584
-12
-0.3% -$1.48K 0.16% 78
2023
Q4
$422K Sell
3,596
-101
-3% -$10.5K 0.16% 76
2023
Q3
$383K Buy
3,697
+36
+1% +$3.88K 0.16% 77
2023
Q2
$422K Buy
3,661
+49
+1% +$5.56K 0.17% 76
2023
Q1
$384K Sell
3,612
-448
-11% -$48.4K 0.16% 80
2022
Q4
$450K Buy
4,060
+409
+11% +$41.8K 0.15% 68
2022
Q3
$320K Buy
3,651
+90
+3% +$8.03K 0.12% 86
2022
Q2
$332K Buy
3,561
+54
+2% +$4.79K 0.13% 81
2022
Q1
$288K Buy
3,507
+86
+3% +$6.78K 0.21% 83
2021
Q4
$278K Sell
3,421
-179
-5% -$14.3K 0.11% 99
2021
Q3
$296K Buy
3,600
+678
+23% +$51.6K 0.11% 94
2021
Q2
$228K Sell
2,922
-323
-10% -$24K 0.1% 101
2021
Q1
$240K Sell
3,245
-167
-5% -$12.3K 0.19% 88
2020
Q4
$266K Buy
+3,412
New +$261K 0.23% 69

Other funds holding MRK

McLean Asset Management's MRK Position: Q1 2026 in Review

McLean Asset Management increased its Merck (MRK) stake by 3.1% in Q1 2026, buying an estimated $13.6K and bringing the position to 3,959 shares worth $476K. The position accounts for 0.08% of the portfolio, ranked #99.

McLean Asset Management first reported a position in MRK in Q4 2020 and has held it in 22 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • McLean Asset Management held 3,959 shares of Merck worth $476K as of Q1 2026.
  • McLean Asset Management bought 118 Merck shares in Q1 2026, an estimated $13.6K.
  • Merck made up 0.08% of McLean Asset Management's portfolio in Q1 2026, its #99 holding.
  • McLean Asset Management first reported a position in Merck in Q4 2020 and has held it in 22 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on McLean Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.